Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) today signed a licence agreement with Qi Kang Medical, Ltd (QKM), a joint venture between Eckert & Ziegler and the Chinese company DC Pharma, for the cyclotron technology used by Eckert & Ziegler to…
- Berlin-based food tech company Formo develops fermentation processes to produce cheese alternatives.
- The €35 million EIB investment is backed by the European Union's InvestEU guarantee.
- This venture debt loan brings Formo’s total financing to…
Model was generated in only two months and sets new industry standard for performance
Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual property rights of the antitumor-associated mucin-1 (TA-MUC1) antibody, gatipotuzumab.
Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular dystrophy with the help of gene-editing. Preclinical research led by the Spuler Lab published in “Nature Communications” now paves…
For years, the idea that "AI will replace radiologists" has been largely speculative. Today, a groundbreaking study published in Nature Medicine provides the first real-world evidence of artificial intelligence's potential to transform breast…
ProBioGen today announces the expansion of both protein and virus manufacturing at its Berlin headquarters. This includes the commissioning of an additional 1000L-scale GMP production line for proteins as well as the completion of the construction…
Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler), a leading provider of isotope technology for nuclear medicine and radiopharmaceutical applications, announces the submission of its GalliaPharm® 68Ge/68Ga Radionuclide Generator for approval in…
International research team describes for the first time the structure and function of the Zorya system, a highly specialised antiviral protection mechanism of bacteria
Slow brain waves make neocortex especially receptive
